Niyazi M, Geisler J, Siefert A, Schwarz SB, Ganswindt U, Garny S, Schnell O, Suchorska B, Kreth FW, Tonn JC, Bartenstein P, Fougre CL, Belka C (2011)
Publication Type: Journal article
Publication year: 2011
Book Volume: 99
Pages Range: 44-48
Journal Issue: 1
DOI: 10.1016/j.radonc.2011.03.001
Background and purpose: The aim of this study was to compare MRI-based morphological gross tumour volumes (GTVs) to biological tumour volumes (BTVs), defined by the pathological radiotracer uptake in positron emission tomography (PET) imaging with 18F-fluoroethyltyrosine (FET), subsequently clinical target volumes (CTVs) and finally planning target volumes (PTVs) for radiotherapy planning of glioblastoma. Patients and methods: Seventeen patients with glioblastoma were included into a retrospective protocol. Treatment-planning was performed using clinical target volume (CTV = BTV + 20 mm or CTV = GTV + 20 mm + inclusion of the edema) and planning target volume (PTV = CTV + 5 mm). Image fusion and target volume delineation were performed with OTP-Masterplan®. Initial gross tumour volume (GTV) definition was based on MRI data only or FET-PET data only (BTV), secondarily both data sets were used to define a common CTV. Results: FET based BTVs (median 43.9 cm3) were larger than corresponding GTVs (median 34.1 cm3, p = 0.028), in 11 of 17 cases there were major differences between GTV/BTV. To evaluate the conformity of both planning methods, the index (CTV
APA:
Niyazi, M., Geisler, J., Siefert, A., Schwarz, S.B., Ganswindt, U., Garny, S.,... Belka, C. (2011). FET-PET for malignant glioma treatment planning. Radiotherapy and Oncology, 99(1), 44-48. https://doi.org/10.1016/j.radonc.2011.03.001
MLA:
Niyazi, Maximilian, et al. "FET-PET for malignant glioma treatment planning." Radiotherapy and Oncology 99.1 (2011): 44-48.
BibTeX: Download